-
1
-
-
2642620230
-
Results of screening 1.9 million Texas newborns for 21-hydroxylase- deficient congenital adrenal hyperplasia
-
DOI 10.1542/peds.101.4.583
-
B.L.J. Therrell, S.A. Berenbaum, V. Manter-Kapanke, J. Simmank, K. Korman, L. Prentice, J. Gonzalez, and S. Gunn Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia Pediatrics 101 1998 583 590 (Pubitemid 28180138)
-
(1998)
Pediatrics
, vol.101
, Issue.4
, pp. 583-590
-
-
Therrell Jr., B.L.1
Berenbaum, S.A.2
Manter-Kapanke, V.3
Simmank, J.4
Korman, K.5
Prentice, L.6
Gonzalez, J.7
Gunn, S.8
-
2
-
-
0022219639
-
High frequency of nonclassical steroid 21-hydroxylase deficiency
-
P.W. Speiser, B. Dupont, P. Rubinstein, A. Piazza, A. Kastelan, and M.I. New High frequency of nonclassical steroid 21-hydroxylase deficiency Am. J. Hum. Genet. 37 1985 650 667 (Pubitemid 16249426)
-
(1985)
American Journal of Human Genetics
, vol.37
, Issue.4
, pp. 650-667
-
-
Speiser, P.W.1
Dupont, B.2
Rubinstein, P.3
-
3
-
-
0842291524
-
Two Prevalent CYP17 Mutations and Genotype-Phenotype Correlations in 24 Brazilian Patients with 17-Hydroxylase Deficiency
-
DOI 10.1210/jc.2003-031021
-
M. Costa-Santos, C.E. Kater, and R.J. Auchus Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency J. Clin. Endocrinol. Metab. 89 2004 49 60 (Pubitemid 38183859)
-
(2004)
Journal of Clinical Endocrinology and Metabolism
, vol.89
, Issue.1
, pp. 49-60
-
-
Costa-Santos, M.1
Kater, C.E.2
Auchus, R.J.3
-
4
-
-
67349085063
-
Genome-wide association study identifies eight loci associated with blood pressure
-
C. Newton-Cheh, T. Johnson, V. Gateva, M.D. Tobin, M. Bochud, L. Coin, S.S. Najjar, J.H. Zhao, S.C. Heath, S. Eyheramendy, K. Papadakis, B.F. Voight, L.J. Scott, F. Zhang, M. Farrall, T. Tanaka, C. Wallace, J.C. Chambers, K.T. Khaw, P. Nilsson, P. van der Harst, S. Polidoro, D.E. Grobbee, N.C. Onland-Moret, M.L. Bots, L.V. Wain, K.S. Elliott, A. Teumer, J. Luan, G. Lucas, J. Kuusisto, P.R. Burton, D. Hadley, W.L. McArdle, M. Brown, A. Dominiczak, S.J. Newhouse, N.J. Samani, J. Webster, E. Zeggini, J.S. Beckmann, S. Bergmann, N. Lim, K. Song, P. Vollenweider, G. Waeber, D.M. Waterworth, X. Yuan, L. Groop, M. Orho-Melander, A. Allione, A. Di Gregorio, S. Guarrera, S. Panico, F. Ricceri, V. Romanazzi, C. Sacerdote, P. Vineis, I. Barroso, M.S. Sandhu, R.N. Luben, G.J. Crawford, P. Jousilahti, M. Perola, M. Boehnke, L.L. Bonnycastle, F.S. Collins, A.U. Jackson, K.L. Mohlke, H.M. Stringham, T.T. Valle, C.J. Willer, R.N. Bergman, M.A. Morken, A. Doring, C. Gieger, T. Illig, T. Meitinger, E. Org, A. Pfeufer, H.E. Wichmann, S. Kathiresan, J. Marrugat, C.J. O'Donnell, S.M. Schwartz, D.S. Siscovick, I. Subirana, N.B. Freimer, A.L. Hartikainen, M.I. McCarthy, P.F. O'Reilly, L. Peltonen, A. Pouta, P.E. de Jong, H. Snieder, W.H. van Gilst, R. Clarke, A. Goel, A. Hamsten, J.F. Peden, U. Seedorf, A.C. Syvanen, G. Tognoni, E.G. Lakatta, S. Sanna, P. Scheet, D. Schlessinger, A. Scuteri, M. Dorr, F. Ernst, S.B. Felix, G. Homuth, R. Lorbeer, T. Reffelmann, R. Rettig, U. Volker, P. Galan, I.G. Gut, S. Hercberg, G.M. Lathrop, D. Zelenika, P. Deloukas, N. Soranzo, F.M. Williams, G. Zhai, V. Salomaa, M. Laakso, R. Elosua, N.G. Forouhi, H. Volzke, C.S. Uiterwaal, Y.T. van der Schouw, M.E. Numans, G. Matullo, G. Navis, G. Berglund, S.A. Bingham, J.S. Kooner, J.M. Connell, S. Bandinelli, L. Ferrucci, H. Watkins, T.D. Spector, J. Tuomilehto, D. Altshuler, D.P. Strachan, M. Laan, P. Meneton, N.J. Wareham, M. Uda, M.R. Jarvelin, V. Mooser, O. Melander, R.J. Loos, P. Elliott, G.R. Abecasis, M. Caulfield, and P.B. Munroe Genome-wide association study identifies eight loci associated with blood pressure Nat. Genet. 41 2009 666 676
-
(2009)
Nat. Genet.
, vol.41
, pp. 666-676
-
-
Newton-Cheh, C.1
Johnson, T.2
Gateva, V.3
Tobin, M.D.4
Bochud, M.5
Coin, L.6
Najjar, S.S.7
Zhao, J.H.8
Heath, S.C.9
Eyheramendy, S.10
Papadakis, K.11
Voight, B.F.12
Scott, L.J.13
Zhang, F.14
Farrall, M.15
Tanaka, T.16
Wallace, C.17
Chambers, J.C.18
Khaw, K.T.19
Nilsson, P.20
Van Der Harst, P.21
Polidoro, S.22
Grobbee, D.E.23
Onland-Moret, N.C.24
Bots, M.L.25
Wain, L.V.26
Elliott, K.S.27
Teumer, A.28
Luan, J.29
Lucas, G.30
Kuusisto, J.31
Burton, P.R.32
Hadley, D.33
McArdle, W.L.34
Brown, M.35
Dominiczak, A.36
Newhouse, S.J.37
Samani, N.J.38
Webster, J.39
Zeggini, E.40
Beckmann, J.S.41
Bergmann, S.42
Lim, N.43
Song, K.44
Vollenweider, P.45
Waeber, G.46
Waterworth, D.M.47
Yuan, X.48
Groop, L.49
Orho-Melander, M.50
Allione, A.51
Di Gregorio, A.52
Guarrera, S.53
Panico, S.54
Ricceri, F.55
Romanazzi, V.56
Sacerdote, C.57
Vineis, P.58
Barroso, I.59
Sandhu, M.S.60
Luben, R.N.61
Crawford, G.J.62
Jousilahti, P.63
Perola, M.64
Boehnke, M.65
Bonnycastle, L.L.66
Collins, F.S.67
Jackson, A.U.68
Mohlke, K.L.69
Stringham, H.M.70
Valle, T.T.71
Willer, C.J.72
Bergman, R.N.73
Morken, M.A.74
Doring, A.75
Gieger, C.76
Illig, T.77
Meitinger, T.78
Org, E.79
Pfeufer, A.80
Wichmann, H.E.81
Kathiresan, S.82
Marrugat, J.83
O'Donnell, C.J.84
Schwartz, S.M.85
Siscovick, D.S.86
Subirana, I.87
Freimer, N.B.88
Hartikainen, A.L.89
McCarthy, M.I.90
O'Reilly, P.F.91
Peltonen, L.92
Pouta, A.93
De Jong, P.E.94
Snieder, H.95
Van Gilst, W.H.96
Clarke, R.97
Goel, A.98
Hamsten, A.99
more..
-
5
-
-
53749090666
-
Phase i clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven
-
G. Attard, A.H. Reid, T.A. Yap, F. Raynaud, M. Dowsett, S. Settatree, M. Barrett, C. Parker, V. Martins, E. Folkerd, J. Clark, C.S. Cooper, S.B. Kaye, D. Dearnaley, G. Lee, and J.S. de Bono Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven J. Clin. Oncol. 26 2008 463 4571
-
(2008)
J. Clin. Oncol.
, vol.26
, pp. 463-4571
-
-
Attard, G.1
Reid, A.H.2
Yap, T.A.3
Raynaud, F.4
Dowsett, M.5
Settatree, S.6
Barrett, M.7
Parker, C.8
Martins, V.9
Folkerd, E.10
Clark, J.11
Cooper, C.S.12
Kaye, S.B.13
Dearnaley, D.14
Lee, G.15
De Bono, J.S.16
-
6
-
-
79957443342
-
Abiraterone and increased survival in metastatic prostate cancer
-
J.S. de Bono, C.J. Logothetis, A. Molina, K. Fizazi, S. North, L. Chu, K.N. Chi, R.J. Jones, O.B. Goodman Jr. , F. Saad, J.N. Staffurth, P. Mainwaring, S. Harland, T.W. Flaig, T.E. Hutson, T. Cheng, H. Patterson, J.D. Hainsworth, C.J. Ryan, C.N. Sternberg, S.L. Ellard, A. Flechon, M. Saleh, M. Scholz, E. Efstathiou, A. Zivi, D. Bianchini, Y. Loriot, N. Chieffo, T. Kheoh, C.M. Haqq, and H.I. Scher Abiraterone and increased survival in metastatic prostate cancer N. Engl. J. Med. 364 2011 1995 2005
-
(2011)
N. Engl. J. Med.
, vol.364
, pp. 1995-2005
-
-
De Bono, J.S.1
Logothetis, C.J.2
Molina, A.3
Fizazi, K.4
North, S.5
Chu, L.6
Chi, K.N.7
Jones, R.J.8
Goodman Jr., O.B.9
Saad, F.10
Staffurth, J.N.11
Mainwaring, P.12
Harland, S.13
Flaig, T.W.14
Hutson, T.E.15
Cheng, T.16
Patterson, H.17
Hainsworth, J.D.18
Ryan, C.J.19
Sternberg, C.N.20
Ellard, S.L.21
Flechon, A.22
Saleh, M.23
Scholz, M.24
Efstathiou, E.25
Zivi, A.26
Bianchini, D.27
Loriot, Y.28
Chieffo, N.29
Kheoh, T.30
Haqq, C.M.31
Scher, H.I.32
more..
-
7
-
-
0027313314
-
Progesterone 16α-hydroxylase activity is catalyzed by human cytochrome P450 17α-hydroxylase
-
DOI 10.1210/jc.77.1.98
-
P. Swart, A.C. Swart, M.R. Waterman, R.W. Estabrook, and J.I. Mason Progesterone 16α-hydroxylase activity is catalyzed by human cytochrome P450 17α-hydroxylase J. Clin. Endocrinol. Metab. 77 1993 98 102 (Pubitemid 23206784)
-
(1993)
Journal of Clinical Endocrinology and Metabolism
, vol.77
, Issue.1
, pp. 98-102
-
-
Swart, P.1
Swart, A.C.2
Waterman, M.R.3
Estabrook, R.W.4
Mason, J.I.5
-
8
-
-
79955868223
-
Why human cytochrome P450c21 is a progesterone 21-hydroxylase
-
D. Mizrachi, Z. Wang, K.K. Sharma, M.K. Gupta, K. Xu, C.R. Dwyer, and R.J. Auchus Why human cytochrome P450c21 is a progesterone 21-hydroxylase Biochemistry 50 2011 3968 3974
-
(2011)
Biochemistry
, vol.50
, pp. 3968-3974
-
-
Mizrachi, D.1
Wang, Z.2
Sharma, K.K.3
Gupta, M.K.4
Xu, K.5
Dwyer, C.R.6
Auchus, R.J.7
-
9
-
-
0033346398
-
Molecular modeling of human p450c17 (17α-hydroxylase/ 17,20-lyase) insights into reaction mechanisms and effects of mutations
-
R.J. Auchus, and W.L. Miller Molecular modeling of human P450c17 (17α-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations Mol. Endocrinol. 13 1999 1169 1182 (Pubitemid 30644304)
-
(1999)
Molecular Endocrinology
, vol.13
, Issue.7
, pp. 1169-1182
-
-
Auchus, R.J.1
Miller, W.L.2
-
12
-
-
84889582115
-
NMR chemical shifts of common laboratory solvents as trace impurities
-
H.E. Gottlieb, V. Kotlyar, and A. Nudelman NMR chemical shifts of common laboratory solvents as trace impurities J. Org. Chem. 62 1997 7512 7515
-
(1997)
J. Org. Chem.
, vol.62
, pp. 7512-7515
-
-
Gottlieb, H.E.1
Kotlyar, V.2
Nudelman, A.3
-
13
-
-
76349100272
-
A new steroidal 5,7-diene derivative, 3β-hydroxyandrosta-5,7-diene- 17β-carboxylic acid, shows potent anti-proliferative activity
-
T.K. Kim, J. Chen, W. Li, J. Zjawiony, D. Miller, Z. Janjetovic, R.C. Tuckey, and A. Slominski A new steroidal 5,7-diene derivative, 3β-hydroxyandrosta-5,7-diene-17β-carboxylic acid, shows potent anti-proliferative activity Steroids 75 2010 230 239
-
(2010)
Steroids
, vol.75
, pp. 230-239
-
-
Kim, T.K.1
Chen, J.2
Li, W.3
Zjawiony, J.4
Miller, D.5
Janjetovic, Z.6
Tuckey, R.C.7
Slominski, A.8
-
14
-
-
0030927680
-
Synthesis of novel 21-trifluoropregnane steroids: Inhibitors of 17α- hydroxylase/17,20-1yase (17α-lyase)
-
DOI 10.1016/S0039-128X(97)00016-0, PII S0039128X97000160
-
V.C. Njar, G.T. Klus, H.H. Johnson, and A.M. Brodie Synthesis of novel 21-trifluoropregnane steroids: inhibitors of 17α-hydroxylase/17,20-lyase (17α-lyase) Steroids 62 1997 468 473 (Pubitemid 27248914)
-
(1997)
Steroids
, vol.62
, Issue.6
, pp. 468-473
-
-
Njar, V.C.O.1
Klus, G.T.2
Johnson, H.H.3
Brodie, A.M.H.4
-
15
-
-
0034693312
-
Amidine-promoted addition of chloroform to carbonyl compounds
-
V.K. Aggarwal, and A. Mereu Amidine-promoted addition of chloroform to carbonyl compounds J. Org. Chem. 65 2000 7211 7212
-
(2000)
J. Org. Chem.
, vol.65
, pp. 7211-7212
-
-
Aggarwal, V.K.1
Mereu, A.2
-
16
-
-
3042534973
-
The action of haloform on the steroid-carbonyl function
-
E. Kaspar, and R. Wiechert The action of haloform on the steroid-carbonyl function Chem. Ber. 91 1958 2664 2670
-
(1958)
Chem. Ber.
, vol.91
, pp. 2664-2670
-
-
Kaspar, E.1
Wiechert, R.2
-
17
-
-
70449197239
-
Steroids and related products.X. 17α-Bromoprogesterone, a new potent gestogen
-
C.R. Engel, and H. Jahnke Steroids and related products.X. 17α-Bromoprogesterone, a new potent gestogen Can. J. Biochem. Physiol. 35 1957 1047 1055
-
(1957)
Can. J. Biochem. Physiol.
, vol.35
, pp. 1047-1055
-
-
Engel, C.R.1
Jahnke, H.2
-
18
-
-
77953283237
-
The synthesis of 17α-fluoroprogesterone
-
R. Deghenghi, and R. Gaudry The synthesis of 17α-fluoroprogesterone Can. J. Chem. 39 1961 1553 1557
-
(1961)
Can. J. Chem.
, vol.39
, pp. 1553-1557
-
-
Deghenghi, R.1
Gaudry, R.2
-
19
-
-
2742603880
-
17α-halogenated progesterones: Orally-active progestins
-
D.J. Marshall, and R. Gaudry 17α-halogenated progesterones: orally-active progestins Can. J. Chem. 38 1960 1495 1504
-
(1960)
Can. J. Chem.
, vol.38
, pp. 1495-1504
-
-
Marshall, D.J.1
Gaudry, R.2
-
20
-
-
77955926541
-
D-ring substituted 1,2,3-triazolyl 20-keto pregnenanes as potential anticancer agents: Synthesis and biological evaluation
-
A.H. Banday, S.A. Shameem, B.D. Gupta, and H.M. Kumar D-ring substituted 1,2,3-triazolyl 20-keto pregnenanes as potential anticancer agents: synthesis and biological evaluation Steroids 75 2010 801 804
-
(2010)
Steroids
, vol.75
, pp. 801-804
-
-
Banday, A.H.1
Shameem, S.A.2
Gupta, B.D.3
Kumar, H.M.4
-
21
-
-
0021911859
-
A facile synthesis of deoxycorticoids
-
M. Numazawa, and M. Nagaoka A facile synthesis of deoxycorticoids J. Org. Chem. 50 1985 81 84
-
(1985)
J. Org. Chem.
, vol.50
, pp. 81-84
-
-
Numazawa, M.1
Nagaoka, M.2
-
22
-
-
33947470861
-
Steroids. LXXXVIII. A new synthesis of desoxycorticosterone acetate and of 16-dehydro-desoxycorticosterone acetate
-
J. Romo, G. Rosenkranz, and F. Sondheimer Steroids. LXXXVIII. A new synthesis of desoxycorticosterone acetate and of 16-dehydro-desoxycorticosterone acetate J. Am. Chem. Soc. 79 1957 5034 5036
-
(1957)
J. Am. Chem. Soc.
, vol.79
, pp. 5034-5036
-
-
Romo, J.1
Rosenkranz, G.2
Sondheimer, F.3
-
24
-
-
1542782363
-
CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding
-
DOI 10.1074/jbc.M307586200
-
D.P. Sherbet, D. Tiosano, K.M. Kwist, Z. Hochberg, and R.J. Auchus CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding J. Biol. Chem. 278 2003 48563 48569 (Pubitemid 41079494)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.49
, pp. 48563-48569
-
-
Sherbet, D.P.1
Tiosano, D.2
Kwist, K.M.3
Hochberg, Z.4
Auchus, R.J.5
-
25
-
-
0028901639
-
A new and efficient synthesis of trifluoromethyl ketones from carboxylic-acids
-
J. Boivin, L. Elkaim, and S.Z. Zard A new and efficient synthesis of trifluoromethyl ketones from carboxylic-acids Tetrahedron 51 1995 2573 2584
-
(1995)
Tetrahedron
, vol.51
, pp. 2573-2584
-
-
Boivin, J.1
Elkaim, L.2
Zard, S.Z.3
-
26
-
-
33646406311
-
Enantioselective fluorination mediated by cinchona alkaloids/selectfluor combinations: A catalytic approach
-
T. Fukuzumi, N. Shibata, M. Sugiura, S. Nakamura, and T. Toru Enantioselective fluorination mediated by cinchona alkaloids/selectfluor combinations: a catalytic approach J. Fluorine Chem. 127 2006 548 551
-
(2006)
J. Fluorine Chem.
, vol.127
, pp. 548-551
-
-
Fukuzumi, T.1
Shibata, N.2
Sugiura, M.3
Nakamura, S.4
Toru, T.5
-
28
-
-
0034973773
-
Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity
-
F.P. Guengerich Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity Chem. Res. Toxicol. 14 2001 611 650 (Pubitemid 32565712)
-
(2001)
Chemical Research in Toxicology
, vol.14
, Issue.6
, pp. 611-650
-
-
Guengerich, F.P.1
-
29
-
-
79955776935
-
17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: Protein structures, functions, and recent progress in inhibitor development
-
S. Marchais-Oberwinkler, C. Henn, G. Moller, T. Klein, M. Negri, A. Oster, A. Spadaro, R. Werth, M. Wetzel, K. Xu, M. Frotscher, R.W. Hartmann, and J. Adamski 17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development J. Steroid Biochem. Mol. Biol. 125 2011 66 82
-
(2011)
J. Steroid Biochem. Mol. Biol.
, vol.125
, pp. 66-82
-
-
Marchais-Oberwinkler, S.1
Henn, C.2
Moller, G.3
Klein, T.4
Negri, M.5
Oster, A.6
Spadaro, A.7
Werth, R.8
Wetzel, M.9
Xu, K.10
Frotscher, M.11
Hartmann, R.W.12
Adamski, J.13
-
30
-
-
79957737745
-
Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: Key tools for studying and treating estrogen-dependent diseases
-
D. Poirier Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: key tools for studying and treating estrogen-dependent diseases J. Steroid Biochem. Mol. Biol. 125 2011 83 94
-
(2011)
J. Steroid Biochem. Mol. Biol.
, vol.125
, pp. 83-94
-
-
Poirier, D.1
-
31
-
-
77956566068
-
18F]Selectfluor bis(triflate)
-
18F]Selectfluor bis(triflate) Angew. Chem. Int. Ed. Engl. 49 2010 6821 6824
-
(2010)
Angew. Chem. Int. Ed. Engl.
, vol.49
, pp. 6821-6824
-
-
Teare, H.1
Robins, E.G.2
Kirjavainen, A.3
Forsback, S.4
Sandford, G.5
Solin, O.6
Luthra, S.K.7
Gouverneur, V.8
-
32
-
-
77951130159
-
Imaging progesterone receptor in breast tumors: Synthesis and receptor binding affinity of fluoroalkyl-substituted analogues of tanaproget
-
H.B. Zhou, J.H. Lee, C.G. Mayne, K.E. Carlson, and J.A. Katzenellenbogen Imaging progesterone receptor in breast tumors: synthesis and receptor binding affinity of fluoroalkyl-substituted analogues of tanaproget J. Med. Chem. 53 2010 3349 3360
-
(2010)
J. Med. Chem.
, vol.53
, pp. 3349-3360
-
-
Zhou, H.B.1
Lee, J.H.2
Mayne, C.G.3
Carlson, K.E.4
Katzenellenbogen, J.A.5
|